Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP



Status:Withdrawn
Conditions:Pneumonia
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:October 2012
End Date:August 2013

Use our guide to learn which trials are right for you!

Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia

This is a prospective interventional study to assess laboratory testing which will identify
the microbial cause of pneumonia. This, in turn, will allow targeted antimicrobial agent
selection for patients with community acquired-pneumonia (CAP).

Hypothesis: 1) To determine if Targeted strategy is non-inferior to Empiric therapy with
respect to outcome endpoints. 2) To assess the use of innovative POC tests allows targeted
narrow-spectrum antimicrobial therapy. 3) To determine if Targeted strategy is superior to
Empiric therapy in patients with viral pneumonia

The study will be conducted at five academic medical university sites with 7 hospitals.
Empiric therapy is defined as selection of antibiotic therapy based on the 2007 ATS-IDSA
guidelines in which broad-spectrum antibiotics are recommended, and microbial cause is
uncertain

Inclusion Criteria:

● Adult patients greater than age 17 years who are initially evaluated in the ED with
symptoms of CAP. This includes those who will be treated as outpatients and those admitted
to the hospital (both ward and ICU).

The definition of CAP is as follows:

- Presence of pulmonary infiltrates on chest radiography. (Initial reading may be
performed by the ED physician - but has to be confirmed by board certified
radiologist for inclusion in the study).

- At least 2 of the following: new onset of cough, productive sputum, shortness of
breath, chest pain, fever > 380C, abnormal chest auscultation, WBC > 12,000 cells/mL.

- Able to provide informed consent

- Read, signed, and dated informed consent document

- Available for follow-up for the planned duration of the study

Exclusion Criteria:

- Patients with underlying immunosuppressive illness (HIV, neutropenia, asplenia,
transplant recipient, cystic fibrosis, receipt of immunosuppressive medications
including corticosteroids, (equivalent of prednisone > 10 mg) cancer chemotherapy, or
anti-tumor necrosis factor agents.

- Patients residing in long-term care facilities
We found this trial at
5
sites
1200 Moursund Street
Houston, Texas 77030
(713) 798-4951
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
?
mi
from
Houston, TX
Click here to add this to my saved trials
Akron, Ohio 44304
?
mi
from
Akron, OH
Click here to add this to my saved trials
Baltimore, Maryland 21218
(410) 516-8000
Johns Hopkins The Johns Hopkins University opened in 1876, with the inauguration of its first...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
500 S Preston St
Louisville, Kentucky
(502) 852-5555
University of Louisville The University of Louisville is a state supported research university located in...
?
mi
from
Louisville, KY
Click here to add this to my saved trials
New York, New York 10003
?
mi
from
New York, NY
Click here to add this to my saved trials